Innovation is a central determinant of the competitiveness of a company. The discovery, development and realization of innovative ideas are, however, bound up with challenges and risks. Against this backdrop, new paths and resources must be demonstrated, particularly for small and mid-sized enterprises (SME). This article is concerned with the open-innovation approach in the pharmaceutical industry and describes the interaction between research and practice to open the existing innovation processes in three SME.
